Elevated intraocular pressure in secondary piggyback intraocular lens implantation
Learn more: Stopping tirzepatide: What to expect & how to manage weight after When should I transition to a maintenance dose of tirzepatide
The article does not say GLP-1 therapy is off limits at that level, only that reduced clearance changes how closely someone should be watched during treatment
According to Cooke, one of the problems is people who use PPIs rarely use them in accordance with U.S
You can read about the FIDELIO-DKD trial and more here
Based on the STEP 1 clinical study, the semaglutide-treated group reported weight loss beginning with the first assessment after randomization at week 4, reaching its lowest reported weight loss at week 60.[2,4] STEP 1 included 1961 patients randomly assigned to treatment with semaglutide or placebo combined with diet and exercise.[4] Dosage Forms And Strengths Semaglutide is currently available as a clear and colorless injectable solution.[2] The injections come in five different pre-filled, disposable, and single-dose pens[2]: 0.25 mg/0.5 mL 0.5 mg/0.5 mL 1 mg/0.5 mL 1.7 mg/0.5 mL 2.4 mg/0.5 mL Safety Common side effects of semaglutide are gastrointestinal-related.[2,5] These are nausea, vomiting, and diarrhea